U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 2846

1.
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial
Viktor Grünwald, Rana R. McKay, Tomas Buchler, Masatoshi Eto, Se Hoon Park, Toshio Takagi, Sylvie Zanetta, Daniel Keizman, Cristina Suárez, Sylvie Négrier, Jae Lyun Lee, Daniele Santini, Jens Bedke, Michael Staehler, Christian Kollmannsberger, Toni K. Choueiri, Robert J. Motzer, Joseph E. Burgents, Ran Xie, Chinyere E. Okpara, Thomas Powles
Int J Cancer. 2025 Apr 1; 156(7): 1326–1335. Published online 2024 Dec 30. doi: 10.1002/ijc.35288
PMCID:
PMC11789451
ArticlePDF–1.1M
2.
Head‐to‐head comparison of palbociclib and ribociclib in first‐line treatment of HR‐positive/HER2‐negative metastatic breast cancer with real‐world data from the OPAL registry
Marc Thill, Mark‐Oliver Zahn, Anja Welt, Arnd Nusch, Matthias Zaiss, Kathrin Engelken, Gabriele Kaltenecker, Kai Ringwald, Katja Gratzke, Stephanie Dille, Lisa Kruggel, Martina Jänicke, Holger Schulz, Volker Hagen, Roland Fricker, Elmar Stickeler, Nadia Harbeck, Achim Wöckel, Thomas Decker
Int J Cancer. 2025 May 1; 156(9): 1770–1782. Published online 2024 Dec 20. doi: 10.1002/ijc.35296
PMCID:
PMC11887017
ArticlePDF–7.2M
3.
Exploiting NRF2‐ARE pathway activation in papillary renal cell carcinoma
Silvia Angori, Harini Lakshminarayanan, Amir Banaei‐Esfahani, Katharina Mühlbauer, Hella Anna Bolck, Olli Kallioniemi, Vilja Pietiäinen, Peter Schraml, Holger Moch
Int J Cancer. 2025 Apr 1; 156(7): 1457–1469. Published online 2024 Dec 20. doi: 10.1002/ijc.35311
PMCID:
PMC11789458
ArticlePDF–1.5M
4.
Interval cancer risk after the upper age limit of screening has been reached: Informing risk stratification in FIT‐based colorectal cancer screening
Brenda J. van Stigt, Iris Lansdorp‐Vogelaar, Manon C. W. Spaander, Anneke J. van Vuuren, Evelien Dekker, Folkert J. van Kemenade, Iris D. Nagtegaal, Monique E. van Leerdam, Esther Toes‐Zoutendijk
Int J Cancer. 2025 May 1; 156(9): 1783–1790. Published online 2024 Dec 19. doi: 10.1002/ijc.35294
PMCID:
PMC11887016
ArticlePDF–729K
5.
A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure
Akinaru Yamamoto, Atsunari Kawashima, Toshihiro Uemura, Kosuke Nakano, Makoto Matsushita, Yu Ishizuya, Kentaro Jingushi, Hiroaki Hase, Kotoe Katayama, Rui Yamaguchi, Nesrine Sassi, Yuichi Motoyama, Satoshi Nojima, Masashi Mita, Tomonori Kimura, Daisuke Motooka, Yuki Horibe, Yohei Okuda, Toshiki Oka, Gaku Yamamichi, Eisuke Tomiyama, Yoko Koh, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Motohide Uemura, Seiya Imoto, Hisashi Wada, Eiichi Morii, Kazutake Tsujikawa, Norio Nonomura
Int J Cancer. 2025 Apr 1; 156(7): 1439–1456. Published online 2024 Dec 18. doi: 10.1002/ijc.35295
PMCID:
PMC11789449
ArticlePDF–5.0M
6.
Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation and/or HPV genotyping in HPV positive women with low‐grade cytology from a population‐based Dutch primary HPV screening trial
Lisanne Verhoef, Maaike C. G. Bleeker, Nicole Polman, Kelsi R. Kroon, Renske D. M. Steenbergen, Renée M. F. Ebisch, Willem J. G. Melchers, Ruud L. M. Bekkers, Anco C. Molijn, Folkert van Kemenade, Chris J. L. M. Meijer, Daniëlle A. M. Heideman, Johannes Berkhof
Int J Cancer. 2025 Mar 1; 156(5): 1065–1073. Published online 2024 Dec 16. doi: 10.1002/ijc.35289
PMCID:
PMC11701402
ArticlePDF–1.9M
7.
NMR‐based metabolomics combined with metabolic pathway analysis reveals metabolic heterogeneity of colorectal cancer tissue at different anatomical locations and stages
Rongzhi Cai, LiXin Ke, Yan Zhao, Jiayun Zhao, Huanian Zhang, Peie Zheng, Lijing Xin, Changchun Ma, Yan Lin
Int J Cancer. 2025 Apr 15; 156(8): 1644–1655. Published online 2024 Dec 4. doi: 10.1002/ijc.35273
PMCID:
PMC11826128
ArticlePDF–3.9M
8.
Type II diabetes and metformin use does not affect colorectal cancer prognosis
Mehrnoosh Shahrivar, Caroline E. Dietrich, Bengt Glimelius, Deborah Saraste, Anna Martling, Christian Buchli, Caroline Nordenvall
Int J Cancer. 2025 May 1; 156(9): 1736–1745. Published online 2024 Nov 27. doi: 10.1002/ijc.35266
PMCID:
PMC11887022
ArticlePDF–1.0M
9.
Disparities in childhood leukemia survival for Asian, Native Hawaiian, and Pacific Islanders in the United States
Mia Hashibe, Kimberly A. Herget, Joshua D. Schiffman, Vivian Y. Chang
Int J Cancer. 2025 Apr 15; 156(8): 1563–1571. Published online 2024 Nov 27. doi: 10.1002/ijc.35259
PMCID:
PMC11826113
ArticlePDF–590K
10.
Environmental tobacco smoking (ETS) and esophageal cancer: A population‐based case‐control study in Jiangsu Province, China
Zi‐Yi Jin, Kuangyu Liu, Gina Wallar, Jin‐Yi Zhou, Li‐Na Mu, Xing Liu, Li‐Ming Li, Na He, Ming Wu, Jin‐Kou Zhao, Zuo‐Feng Zhang
Int J Cancer. 2025 Apr 15; 156(8): 1552–1562. Published online 2024 Nov 18. doi: 10.1002/ijc.35254
PMCID:
PMC11826109
ArticlePDF–753K
11.
Sex‐ and site‐specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort
Robin Reichmann, Katharina Nimptsch, Tobias Pischon, Marc J. Gunter, Mazda Jenab, Anne Kirstine Eriksen, Anne Tjonneland, Jürgen Janke, Verena Katzke, Rudolf Kaaks, Matthias B. Schulze, Fabian Eichelmann, Giovanna Masala, Sabina Sieri, Fabrizio Pasanisi, Rosario Tumino, Maria Teresa Giraudo, Joseph Rothwell, Gianluca Severi, Paula Jakszyn, Maria Jose Sanchez‐Perez, Pilar Amiano, Sandra M. Colorado‐Yohar, Marcela Guevara, Bethany van Guelpen, Elom K. Aglago, Alicia K. Heath, Karl Smith‐Byrne, Elisabete Weiderpass, Krasimira Aleksandrova
Int J Cancer. 2025 Mar 1; 156(5): 930–942. Published online 2024 Nov 7. doi: 10.1002/ijc.35205
PMCID:
PMC11701386
ArticlePDF–3.1M
12.
Total testosterone, sex hormone‐binding globulin, and free testosterone concentrations and risk of primary liver cancer: A prospective analysis of 200,000 men and 180,000 postmenopausal women
Cody Z. Watling, Rebecca K. Kelly, Eleanor L. Watts, Barry I. Graubard, Jessica L. Petrick, Charles E. Matthews, Katherine A. McGlynn
Int J Cancer. 2025 Apr 15; 156(8): 1518–1528. Published online 2024 Nov 5. doi: 10.1002/ijc.35244
PMCID:
PMC11826138
ArticlePDF–2.0M
13.
A randomized trial of early cardiotoxicity in breast cancer patients receiving postoperative IMRT with or without serial cardiac dose constraints
Lu Cao, Dan Ou, Wei‐Xiang Qi, Cheng Xu, Ming Ye, Yue‐Hua Fang, Mei Shi, Xiao‐Bo Huang, Qing Lin, Tong Liu, Gang Cai, Rong Cai, Mei Chen, Yi‐Bin Zhang, Xiu‐Xiu Su, Xiao‐Fang Qian, Kun‐Wei Shen, Jia‐Yi Chen
Int J Cancer. 2025 Mar 15; 156(6): 1213–1224. Published online 2024 Nov 5. doi: 10.1002/ijc.35245
PMCID:
PMC11737017
ArticlePDF–2.6M
14.
Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Results of Polish multicenter observational study
Tomasz Wojciech Rutkowski, Agata Kurczyk, Katarzyna Drosik‐Rutowicz, Dorota Kiprian, Izabella Dębicka, Ewa Sierko, Monika Konopka‐Filippow, Joanna Kaźmierska, Monika Łukasiewicz‐Grella, Diana Cząstkiewicz‐Trawińska, Izolda Mrochem‐Domin, Iwona Ryniewicz‐Zander, Zuzanna Borysiewicz, Ewa Chmielowska, Marek Jasiówka, Monika Źrebiec‐Figura, Agnieszka Karpińska, Renata Pacholczak‐Madej, Dominika Leś, Agnieszka Pietruszka, Izabela Łasinska, Krzysztof Składowski
Int J Cancer. 2025 Mar 1; 156(5): 1074–1084. Published online 2024 Nov 5. doi: 10.1002/ijc.35248
PMCID:
PMC11701412
ArticlePDF–2.2M
15.
Nationwide cohort study on the risk of high‐grade cervical dysplasia and carcinoma after conservative treatment or hysterectomy for adenocarcinoma in situ
Mirte Schaafsma, Teska N. Schuurman, Pien Kootstra, Deli Issa, Ivo Hermans, Maaike C. G. Bleeker, Petra L. M. Zusterzeel, Ruud L. M. Bekkers, Albert G. Siebers, Constantijne H. Mom, Nienke E. van Trommel
Int J Cancer. 2025 Mar 15; 156(6): 1203–1212. Published online 2024 Nov 4. doi: 10.1002/ijc.35237
PMCID:
PMC11736995
ArticlePDF–1.2M
16.
Cervical cancer screening: Sharing best practices and addressing common challenges in cervical cancer screening programs
Philippe Descamps, Francesc Xavier Bosch Jose, Joseph Monsonego, Ody Neisingh, Lananh Nguyen, Mairead O'Connor
Int J Cancer. 2025 Feb 1; 156(3): 679–681. Published online 2024 Oct 26. doi: 10.1002/ijc.35220
PMCID:
PMC11621996
ArticlePDF–186K
17.
Acceptability and validity of HPV self‐sampling for cervical cancer screening among women living in different ecological settings in India
Gauravi A. Mishra, Sharmila A. Pimple, Kavita V. Anand, Vasundhara Y. Kulkarni, Anil S. Patil, Sanjay K. Biswas
Int J Cancer. 2025 Mar 15; 156(6): 1142–1153. Published online 2024 Oct 16. doi: 10.1002/ijc.35222
PMCID:
PMC11737002
ArticlePDF–959K
18.
TP53 mutations and survival in ovarian carcinoma patients receiving first‐line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV‐2 study
Eliana Bignotti, Vittorio Simeon, Laura Ardighieri, Elisabetta Kuhn, Sergio Marchini, Daniela Califano, Sabrina Chiara Cecere, Mattia Bugatti, Anna Spina, Giosuè Scognamiglio, Lara Paracchini, Daniela Russo, Laura Arenare, Germana Tognon, Domenica Lorusso, Luca Beltrame, Maurizio D'Incalci, Enrico Sartori, Andrea De Censi, Franco Odicino, Francesco Perrone, Paolo Chiodini, Sandro Pignata
Int J Cancer. 2025 Mar 1; 156(5): 1085–1096. Published online 2024 Oct 16. doi: 10.1002/ijc.35203
PMCID:
PMC11701406
ArticlePDF–2.9M
19.
Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charité Comprehensive Cancer Centre analysis
Annika Strönisch, Daniel Rau, Silvan Wittenberg, David Kaul, Georgios Koulaxouzidis, Robert Öllinger, Maximilian von Laffert, Armin Jarosch, Frederik Schäfer, Ulrich Keilholz, Lars Bullinger, Sven Märdian, Jana Striefler, Anne Flörcken
Int J Cancer. 2025 Feb 15; 156(4): 802–816. Published online 2024 Oct 16. doi: 10.1002/ijc.35201
PMCID:
PMC11661508
ArticlePDF–1.4M
20.
Cytokine‐armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56dimCD16dim natural killer cells
Ruonan Wang, Mengwen Hu, Isis Lozzi, Cao Zhong Jing Jin, Dou Ma, Katrin Splith, Jörg Mengwasser, Vincent Wolf, Linda Feldbrügge, Peter Tang, Lea Timmermann, Karl Herbert Hillebrandt, Marieluise Kirchner, Philipp Mertins, Georg Hilfenhaus, Christopher Claudius Maximilian Neumann, Thomas Kammertoens, Johann Pratschke, Thomas Malinka, Igor Maximillian Sauer, Elfriede Noessner, Zong Sheng Guo, Matthäus Felsenstein
Int J Cancer. 2025 Feb 1; 156(3): 638–651. Published online 2024 Oct 14. doi: 10.1002/ijc.35209
PMCID:
PMC11621990
ArticlePDF–7.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center